The Neurodegeneration Panel Consortium was formed as a collaboration to bring together leading researchers in the neuroscience community. Consortium members contributed their expertise to the design and development of a sequencing panel for neurodegenerative disease research.

The TruSeq Neurodegeneration Panel is a targeted next-generation sequencing (NGS) panel that covers 118 risk genes associated with common neurodegenerative diseases, including Alzheimer’s Disease, Parkinson's Disease, and others.